References
- Kalra S, Kishor K, Khandelwal D. Atrial fibrillation: the endocrine connection. J Pak Med Assoc. 2019;69(11):1746–1749.
- Verma KP, Wong M. Atrial fibrillation. Aust J Gen Pract. 2019;48(10):694–699.
- Seccia TM, Caroccia B, Maiolino G, et al. Arterial hypertension, aldosterone, and atrial fibrillation. Curr Hypertens Rep. 2019;21(12):94.
- Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020;106(1):10–17.
- Packer M. HFpEFis the substrate for stroke in obesity and diabetes independent of atrial fibrillation. J ACC Heart Fail. 2020;8(1):35–42.
- Costantini O. Basic principles of cardiac electrophysiology. Med Clin North Am. 2019;103(5):767–774.
- Lu Q, Wu R, Zhao M, et al. miRNAs as therapeutic targets in inflammatory disease. Trends Pharmacol Sci. 2019;40(11):853–865.
- Lin YK, Chen YA, Lee TI, et al. Aging modulates the substrate and triggers remodeling in atrial fibrillation. Circ J. 2018;82(5):1237–1244.
- Komal S, Yin JJ, Wang SH, et al. MicroRNAs: emerging biomarkers for atrial fibrillation. J Cardiol. 2019;74(6):475–482.
- Sucharov CC, Kao DP, Port JD, et al. Myocardial microRNAs associated with reverse remodeling in human heart failure. JCI Insight. 2017;2(2):e89169.
- Bejerano T, Etzion S, Elyagon S, et al. Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Lett. 2018;18(9):5885–5891.
- Terlecki-Zaniewicz L, Lämmermann I, Latreille J, et al. Small extracellular vesicles and their miRNA cargo are anti-apoptotic members of the senescence-associated secretory phenotype. Aging (Albany NY). 2018;10(5):1103–1132.
- Li YD, Hong YF, Yusufuaji Y, et al. Altered expression of hyperpolarization-activated cyclic nucleotide-gated channels and microRNA-1 and −133 in patients with age-associated atrial fibrillation. Mol Med Rep. 2015;12(3):3243–3248.
- Iezzoni JC. Diagnostic histochemistry in hepatic pathology. Semin Diagn Pathol. 2018 Nov;35(6):381–389.
- Majtnerová P, Roušar T. An overview of apoptosis assays detecting DNA fragmentation. Mol Biol Rep. 2018 Oct;45(5):1469–1478.
- Watanabe K, Akutsu T. Evaluation of a co-extraction kit for mRNA, miRNA and DNA methylation-based body fluid identification. Leg Med (Tokyo). 2020 Feb;42:101630.
- Lowres N, Olivier J, Chao TF, et al. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals. PLoS Med. 2019;16(9):e1002903.
- van Den Berg NWE, Kawasaki M, Berger WR, et al. MicroRNAs in atrial fibrillation: from expression signatures to functional implications. Cardiovasc Drugs Ther. 2017;31(3):345–365.
- Shen NN, Zhang C, Li Z, et al. MicroRNA expression signatures of atrial fibrillation: the critical systematic review and bioinformatics analysis. Exp Biol Med (Maywood). 2020;245(1):42–53.
- Ma ZW, Zhang K, Wang WD, et al. Tolvaptan attenuates atrial remodeling in rats undergoing chronic intermittent hypoxia via miRNA-21. ZhonghuaXin Xue Guan Bing Za Zhi. 2019;47(8):614–621.
- Nattel S. Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation. JACC Clin Electrophysiol. 2017;3(5):425–435.
- Wu L, Luo Z, Zheng J, et al. IL-33 can promote the process of pulmonary fibrosis by inducing the imbalance between MMP-9 and TIMP-1. Inflammation. 2018;41(3):878–885.
- Diao SL, Xu HP, Zhang B, et al. Associations of MMP-2, BAX, and Bcl-2 mRNA and protein expressions with development of atrial fibrillation. Med Sci Monit. 2016;22:1497–1507.
- Tsoporis JN, Fazio A, Rizos IK, et al. Increased right atrial appendage apoptosis is associated with differential regulation of candidate microRNAs 1 and 133A in patients who developed atrial fibrillation after cardiac surgery. J Mol Cell Cardiol. 2018;121:25–32.